Comparative Effectiveness And Cost-Effectiveness Analyses Frequently Agree On Value
نویسندگان
چکیده
منابع مشابه
The Core Value of Cost-Effectiveness Analyses.
O ver the past 4 years, transcatheter aortic valve replacement (TAVR) has transformed the cardiac care of patients in the United States with severe aortic stenosis (SAS). In September 2011, a balloon-expandable prosthesis (Sapien, Edwards Lifesciences, Irvine, California) received U.S. Food and Drug Administration (FDA) approval for the treatment of inoperable patients on the basis of a randomi...
متن کاملCost, effectiveness, and cost-effectiveness.
Incremental or marginal cost-effectiveness ratios are founded on a number of assumptions that weaken their suitability as a way to balance competing economic and clinical priorities. We therefore propose a more relevant and responsible way to gauge the impact of clinical management strategies based on “consumer protection” principles—explicit disclosure of (1) the total magnitude of expected be...
متن کاملAddressing risk preferences in cost-effectiveness analyses.
Cost-effectiveness analysis is a form of economic evaluation that compares that compares the costs and effectiveness of health interventions, where effectiveness is measured in a single scale. Despite the growth in the popularity of cost-effectiveness analysis, very few cost-effectiveness analyses adequately measure and account for uncertainty. In the health economics literature, two schools of...
متن کاملCardiovascular Perspectives Cost, Effectiveness, and Cost-Effectiveness
Incremental or marginal cost-effectiveness ratios are founded on a number of assumptions that weaken their suitability as a way to balance competing economic and clinical priorities. We therefore propose a more relevant and responsible way to gauge the impact of clinical management strategies based on “consumer protection” principles— explicit disclosure of (1) the total magnitude of expected b...
متن کاملPredicting survival in cost-effectiveness analyses based on clinical trials.
This study deals with the question of how to model health effects after the cessation of a randomized controlled trial (RCT). By using clinical trial data on severe congestive heart failure patients, we illustrate how survival beyond the cessation of an RCT can be predicted based on parametric survival models. In the analysis, we compare predicted survival and the resulting incremental cost-eff...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Health Affairs
سال: 2015
ISSN: 0278-2715,1544-5208
DOI: 10.1377/hlthaff.2014.0552